Manufacturer or GPO Program year 2025 Source: CMS Open Payments

Alcon Puerto Rico Inc

PR, United States

CMS manufacturer 100000005436

Open in the dashboard

General payments

$39,095

578 payments

Research payments

$0

0 payments

Ownership & investment interest

$0

None reported

Through program year 2025, Alcon Puerto Rico Inc reported paying $39,095 in general payments and $0 in research payments to U.S. physicians, teaching hospitals and other recipients.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

6 rows
Year Kind Amount Payments
2025 General $7,042 108
2024 General $5,035 79
2023 General $11,978 188
2022 General $4,775 75
2021 General $2,018 25
2019 General $8,246 103

Breakdown

Top recipients General payments · program year 2025
  1. Ian Piovanetti Ophthalmology · San Juan, PR $216 3 payments
  2. Sofia Ramos Bartolomei Ophthalmology · San Juan, PR $190 4 payments
  3. Hiram Jimenez Davila Ophthalmology · San Juan, PR $190 4 payments
  4. Sofia Muns Aponte Ophthalmology · Cayey, PR $190 4 payments
  5. Esteban Vazquez-Valencia Ophthalmology · San Juan, PR $163 2 payments
  6. Francisco Guevara Glaucoma Specialist · Aguada, PR $163 2 payments
  7. Maria Berrocal Fernandez Ophthalmology · San Juan, PR $154 2 payments
  8. Natalia Gonzalez Ophthalmology · San Juan, PR $153 3 payments
  9. Elsie De La Texera Optometrist · Carolina, PR $142 2 payments
  10. Maria Velazquez Lamela Glaucoma Specialist · Caguas, PR $138 2 payments
Products the payments named General payments · program year 2025
  1. Unity Ophthalmology $3,140 45% · 33 recipients
  2. Clareon PanOptix Pro Ophthalmology $1,626 23% · 22 recipients
  3. Clareon Ophthalmology $959 14% · 13 recipients
  4. Precision7 Ophthalmology $803 11% · 10 recipients
  5. Clareon Ophthalmology $169 2% · 11 recipients

The top 5 of 9 products; each share is of this company’s general payments naming a product in 2025. A payment can name up to five products, so these amounts overlap.

The top 25 products, free in the app

Specialties paid General payments · program year 2025
  1. Ophthalmology $5,037 72% · 54 practitioners
  2. Optometrist $803 11% · 10 practitioners
  3. Retina Specialist Ophthalmology $573 8% · 6 practitioners
  4. Glaucoma Specialist Ophthalmology $316 4% · 3 practitioners
  5. Cornea and External Diseases Specialist Ophthalmology $207 3% · 3 practitioners

The top 5 of 7 specialties; each share is of this company’s general payments to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Puerto Rico $6,389 91% · 70 recipients
  2. Illinois $185 3% · 2 recipients
  3. Pennsylvania $132 2% · 1 recipient
  4. North Carolina $83 1% · 1 recipient
  5. California $83 1% · 1 recipient

The top 5 of 8 states; each share is of this company’s general payments in 2025 where a state was reported.

The top 25 states, free in the app

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $39,095 578 payments
Companies with a similar name General payments · program years 2019–2025
  1. Alcon Vision LLC TX, United States $99,438,550
  2. Alcon Research LLC TX, United States $20,594,180
  3. Alcon Pharmaceuticals Ltd Switzerland $164,601
  4. Alcon Grieshaber AG Switzerland $413

Grouped by name only. CMS publishes no corporate ownership, so a shared name does not mean a shared parent.

578 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers of drugs, devices and biologicals, and group purchasing organisations, are required to report the payments and transfers of value they make to physicians and teaching hospitals. This page shows what this company reported.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record